Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska native persons from 2000 to 2008

Journal of Clinical Microbiology

Volumn 49, Issue 10, 2011, Pages 3638-3643

  Tveit, Adrienne H ^a   Bruce, Michael G ^a   Bruden, Dana L ^a   Morris, Julie ^a   Reasonover, Alisa ^a   Hurlburt, Debby A ^a   Hennessy, Thomas W ^a   McMahon, Brian ^a  

^a ALASKA NATIVE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; TETRACYCLINE;

ADOLESCENT; ADULT; AGAR DILUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPSILOMETER TEST; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SCHOOL CHILD; SENTINEL SURVEILLANCE; SEX DIFFERENCE; UNITED STATES; URBAN AREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALASKA; ANTI-BACTERIAL AGENTS; BIOPSY; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POPULATION GROUPS; PREVALENCE; SENTINEL SURVEILLANCE; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 80053480624     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01067-11     Document Type: Article

References (28)

1. Bardhan, P. K. 1997. Epidemiological features of Helicobacter pylori infection in developing countries. Clin. Infect. Dis. 25:973-978. (Pubitemid 27513169)
2. Bayerdorffer, E., et al. 1995. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345:1591-1594.
3. Best, L. G., D. Haldane, and S. Veldhuyzen van Zanten. 2004. Helicobacter pylori antibiotic resistance in Canadian populations. Gastroenterology 126: 1293.
4. Bott, A. M., M. G. Bruce, L. Bulkow, J. Coleman, and T. W. Hennessy. 2009. Trends in antimicrobial prescribing rates for Alaska Native and American Indian persons <18 years of age residing in the Anchorage region. Int. J. Circumpolar Health 68:337-346.
5. Boyanova, L., et al. 2006. Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years. J. Med. Microbiol. 55:65-68. (Pubitemid 43031240)
6. Bruce, M. G., et al. 2006. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003. Helicobacter 11:581-588. (Pubitemid 44674144)
7. Bruce, M. G., and H. I. Maaroos. 2008. Epidemiology of Helicobacter pylori infection. Helicobacter 13(Suppl. 1):1-6.
8. Bruden, D. B., et al. Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population. World J. Gastroenterol., in press.
9. Cabrita, J., et al. 2000. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999). J. Antimicrob. Chemother. 46:1029-1031. (Pubitemid 32000618)
10. Carothers, J. J., et al. 2007. The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. Clin. Infect. Dis. 44:e5-e8.
11. Ching, C. K., et al. 1996. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut 38:675-678. (Pubitemid 26167473)
12. Duck, W. M., et al. 2004. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg. Infect. Dis. 10:1088-1094. (Pubitemid 38697703)
13. Kim, J. M., J. S. Kim, N. Kim, H. C. Jung, and I. S. Song. 2005. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J. Antimicrob. Chemother. 56:965-967. (Pubitemid 41631929)
14. Koch, A., M. Bruce, and P. Homoe. 2008. Infectious diseases, p. 265-290. In T. K. Young and P. Bjerregaard (ed.), Health transitions in Arctic populations. University of Toronto Press, Toronto, Canada.
15. Kusters, J. G., A. H. Van Vliet, and E. J. Kuipers. 2006. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19:449-490. (Pubitemid 44134306)
16. Lee, M. G., et al. 2004. Antibiotic sensitivity of Helicobacter pylori in Jamaica. West Indian Med. J. 53:374-377. (Pubitemid 40485190)
17. Liou, J. M., et al. 2010. Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Gut 59:572-578.
18. McMahon, B. J., et al. 2006. Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives. Aliment. Pharmacol. Ther. 23:1215-1223. (Pubitemid 43779362)
19. McMahon, B. J., et al. 2003. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann. Intern. Med. 139:463-469.
20. Megraud, F. 2004. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53:1374-1384. (Pubitemid 39120130)
21. Meyer, J. M., et al. 2002. Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann. Intern. Med. 136:13-24. (Pubitemid 34038693)
22. National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial susceptibility testing. M100-S10. National Committee for Clinical Laboratory Standards, Wayne, PA.
23. Parkinson, A. J., et al. 2000. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin. Diagn. Lab. Immunol. 7:885-888. (Pubitemid 32244483)
24. Sacco, F., M. G. Bruce, B. J. McMahon, and D. Bruden. 2007. A prospective evaluation of 200 upper endoscopies performed in Alaska Native persons. Int. J. Circumpolar Health 66:144-152.
25. Suzuki, H., T. Nishizawa, and T. Hibi. 2010. Helicobacter pylori eradication therapy. Future Microbiol. 5:639-648.
26. Tankovic, J., C. Lascols, Q. Sculo, J. C. Petit, and C. J. Soussy. 2003. Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 47:3942-3944. (Pubitemid 37485011)
27. Tytgat, G. N., and E. A. Rauws. 1990. Campylobacter pylori and its role in peptic ulcer disease. Gastroenterol. Clin. North Am. 19:183-196. (Pubitemid 20232544)
28. Zullo, A., et al. 2007. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment. Pharmacol. Ther. 25:1429-1434. (Pubitemid 46848887)